Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Yong-Chen Lu

Concepts (179)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
13
2022
170
4.480
 Why?
Receptors, Antigen, T-Cell
10
2022
50
3.320
 Why?
Lymphocytes, Tumor-Infiltrating
17
2022
74
3.220
 Why?
Immunotherapy, Adoptive
8
2019
134
2.800
 Why?
T-Lymphocytes
9
2022
373
2.610
 Why?
Neoplasms
9
2022
1316
2.060
 Why?
Immunotherapy
5
2021
263
1.800
 Why?
Cancer Vaccines
4
2021
103
1.470
 Why?
High-Throughput Nucleotide Sequencing
3
2021
206
1.310
 Why?
Mutation
12
2019
1501
0.950
 Why?
CD4-Positive T-Lymphocytes
4
2022
180
0.850
 Why?
Single-Cell Analysis
3
2022
56
0.830
 Why?
Immune System
1
2020
49
0.730
 Why?
Alcohol Oxidoreductases
1
2019
14
0.700
 Why?
HLA-DP beta-Chains
2
2017
2
0.660
 Why?
Neoplasm Proteins
2
2017
359
0.620
 Why?
Genetic Therapy
2
2017
121
0.610
 Why?
Urinary Bladder Neoplasms
1
2019
173
0.610
 Why?
DNA-Binding Proteins
1
2019
462
0.550
 Why?
Melanoma
3
2016
313
0.550
 Why?
CD8-Positive T-Lymphocytes
7
2022
116
0.520
 Why?
Proto-Oncogene Proteins p21(ras)
4
2019
69
0.500
 Why?
Immunodominant Epitopes
2
2015
12
0.500
 Why?
Protein Phosphatase 1
1
2013
6
0.470
 Why?
Phosphoprotein Phosphatases
1
2013
20
0.460
 Why?
Cytokines
4
2019
676
0.450
 Why?
Proto-Oncogene Proteins c-rel
2
2010
5
0.450
 Why?
Lymphocyte Activation
5
2021
197
0.450
 Why?
Humans
29
2022
54284
0.400
 Why?
Antibodies, Monoclonal
1
2016
562
0.400
 Why?
Colorectal Neoplasms
3
2019
236
0.390
 Why?
Neoplasm Metastasis
3
2022
252
0.380
 Why?
CCAAT-Enhancer-Binding Protein-beta
1
2009
4
0.350
 Why?
Animals
11
2022
14385
0.350
 Why?
Toll-Like Receptors
1
2009
25
0.350
 Why?
Lipopolysaccharides
2
2022
199
0.350
 Why?
CCAAT-Enhancer-Binding Protein-delta
1
2009
25
0.340
 Why?
Transcriptome
2
2022
346
0.340
 Why?
Glioblastoma
2
2021
99
0.330
 Why?
Toll-Like Receptor 4
1
2008
51
0.310
 Why?
Signal Transduction
5
2019
1753
0.300
 Why?
Adoptive Transfer
3
2018
38
0.280
 Why?
Cells, Cultured
5
2021
1737
0.260
 Why?
Gene Expression Profiling
2
2021
1138
0.260
 Why?
Autoantigens
2
2015
64
0.250
 Why?
T-Lymphocytes, Regulatory
2
2016
85
0.240
 Why?
Gene Library
2
2014
50
0.240
 Why?
Nephritis
1
2022
27
0.210
 Why?
Receptors, Immunologic
1
2022
37
0.210
 Why?
Clone Cells
2
2019
89
0.210
 Why?
HLA-A Antigens
2
2019
13
0.200
 Why?
Ureteral Obstruction
1
2022
70
0.200
 Why?
Human papillomavirus 16
1
2021
48
0.200
 Why?
Adaptor Proteins, Signal Transducing
2
2014
208
0.200
 Why?
Tumor Suppressor Protein p53
2
2022
250
0.200
 Why?
T-Cell Antigen Receptor Specificity
2
2017
5
0.190
 Why?
Membrane Glycoproteins
1
2022
269
0.190
 Why?
Papillomavirus Vaccines
1
2021
68
0.190
 Why?
Middle Aged
8
2019
13088
0.180
 Why?
Interleukin-2
2
2017
75
0.180
 Why?
Smad5 Protein
1
2019
1
0.170
 Why?
Mucin-4
1
2019
1
0.170
 Why?
Renal Insufficiency, Chronic
1
2022
182
0.170
 Why?
Uterine Cervical Neoplasms
1
2021
276
0.170
 Why?
Cell Differentiation
1
2021
720
0.160
 Why?
Administration, Intravenous
1
2017
75
0.150
 Why?
Epitopes, T-Lymphocyte
2
2014
33
0.150
 Why?
Hematopoietic Stem Cell Transplantation
1
2022
573
0.150
 Why?
Colonic Neoplasms
1
2019
164
0.150
 Why?
Membrane Proteins
1
2019
389
0.150
 Why?
Exome
2
2014
51
0.150
 Why?
Flow Cytometry
3
2016
546
0.140
 Why?
CTLA-4 Antigen
1
2016
29
0.140
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
46
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2016
40
0.140
 Why?
Cell Line, Tumor
2
2017
1550
0.140
 Why?
Transplantation, Autologous
1
2017
476
0.140
 Why?
Gene Expression Regulation
2
2019
1062
0.130
 Why?
Transcription Factors
1
2019
622
0.130
 Why?
Protein Binding
2
2014
736
0.130
 Why?
Gastrointestinal Neoplasms
1
2015
46
0.130
 Why?
Neutrophils
2
2014
154
0.130
 Why?
Male
6
2019
27334
0.130
 Why?
Adult
7
2021
14207
0.130
 Why?
Hepatitis B e Antigens
1
2014
2
0.130
 Why?
Respiratory Burst
1
2014
4
0.130
 Why?
Histocompatibility Antigens
1
2014
6
0.130
 Why?
Epitope Mapping
1
2014
12
0.130
 Why?
Chemotaxis, Leukocyte
1
2014
20
0.130
 Why?
Treatment Outcome
4
2021
5604
0.130
 Why?
Bile Ducts, Intrahepatic
1
2014
17
0.120
 Why?
Time Factors
2
2021
3213
0.120
 Why?
Gene Expression Regulation, Neoplastic
1
2019
866
0.120
 Why?
Aged
2
2019
10054
0.120
 Why?
Cholangiocarcinoma
1
2014
30
0.120
 Why?
Bile Duct Neoplasms
1
2014
33
0.120
 Why?
Th1 Cells
1
2014
50
0.120
 Why?
Monocytes
1
2014
156
0.120
 Why?
Alleles
1
2014
277
0.120
 Why?
Female
10
2021
28441
0.110
 Why?
Gene Knockdown Techniques
1
2013
125
0.110
 Why?
Peptides
1
2014
276
0.110
 Why?
Amino Acid Sequence
1
2014
767
0.110
 Why?
NF-kappa B
2
2011
335
0.110
 Why?
Genes, T-Cell Receptor
2
2022
5
0.110
 Why?
TNF Receptor-Associated Factor 2
1
2011
4
0.110
 Why?
Base Sequence
1
2013
719
0.100
 Why?
Autoimmunity
1
2011
38
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
673
0.100
 Why?
Forkhead Transcription Factors
1
2012
118
0.100
 Why?
Molecular Sequence Data
1
2013
980
0.100
 Why?
Disease Progression
1
2014
913
0.100
 Why?
Cell Line
1
2014
1153
0.100
 Why?
Lung Neoplasms
1
2016
642
0.090
 Why?
Clinical Trials as Topic
1
2013
490
0.090
 Why?
Clonal Anergy
1
2010
14
0.090
 Why?
Protein Kinase C
1
2010
65
0.090
 Why?
Dendritic Cells
2
2022
142
0.090
 Why?
Remission Induction
2
2021
221
0.090
 Why?
Interleukin-1 Receptor-Associated Kinases
1
2009
11
0.090
 Why?
Isoenzymes
1
2010
177
0.090
 Why?
Myeloid Differentiation Factor 88
1
2009
40
0.090
 Why?
Mice
4
2022
6413
0.090
 Why?
Transcriptional Activation
1
2009
134
0.080
 Why?
Breast Neoplasms
1
2018
1248
0.080
 Why?
Inflammation Mediators
1
2009
128
0.080
 Why?
Antineoplastic Agents
1
2017
1300
0.080
 Why?
Antigen Presentation
2
2019
28
0.080
 Why?
Complement C3a
1
2007
3
0.080
 Why?
Complement C5a
1
2007
4
0.080
 Why?
Cell Separation
2
2019
107
0.080
 Why?
Macrophages
1
2009
405
0.070
 Why?
Lymphocyte Count
2
2016
23
0.060
 Why?
Th17 Cells
1
2022
26
0.050
 Why?
Clinical Trials, Phase I as Topic
1
2021
30
0.050
 Why?
Neoplasm Grading
1
2021
131
0.050
 Why?
Gene Regulatory Networks
1
2022
124
0.050
 Why?
Arginine
1
2022
182
0.050
 Why?
Host-Pathogen Interactions
1
2021
143
0.050
 Why?
Nitric Oxide
1
2022
298
0.040
 Why?
Blotting, Western
2
2011
683
0.040
 Why?
Transduction, Genetic
1
2019
50
0.040
 Why?
Lung
2
2016
507
0.040
 Why?
Immunologic Memory
1
2019
32
0.040
 Why?
Transplantation Conditioning
1
2019
86
0.040
 Why?
Coculture Techniques
1
2019
160
0.040
 Why?
Molecular Targeted Therapy
1
2019
128
0.040
 Why?
Neoplastic Cells, Circulating
1
2019
93
0.040
 Why?
Phenotype
2
2012
820
0.040
 Why?
Lymphatic Metastasis
1
2019
256
0.040
 Why?
HLA-DRB1 Chains
1
2017
8
0.040
 Why?
Proteasome Endopeptidase Complex
1
2018
131
0.040
 Why?
Antigen-Presenting Cells
1
2017
25
0.040
 Why?
Cell Proliferation
1
2021
1096
0.040
 Why?
Cross Reactions
1
2016
56
0.040
 Why?
Pilot Projects
1
2019
808
0.040
 Why?
HLA-C Antigens
1
2015
4
0.030
 Why?
ras Proteins
1
2015
70
0.030
 Why?
Inflammation
2
2011
674
0.030
 Why?
Proto-Oncogene Proteins
1
2015
169
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2014
51
0.030
 Why?
Chemokines
1
2014
96
0.030
 Why?
Vaccination
1
2016
294
0.030
 Why?
Receptor, erbB-2
1
2014
79
0.030
 Why?
B-Lymphocytes
1
2014
176
0.030
 Why?
Recombinant Proteins
1
2014
569
0.030
 Why?
Dose-Response Relationship, Immunologic
1
2012
16
0.030
 Why?
Whole-Body Irradiation
1
2012
160
0.020
 Why?
Polymerase Chain Reaction
1
2011
531
0.020
 Why?
Mice, Knockout
1
2011
926
0.020
 Why?
Apoptosis
1
2014
1300
0.020
 Why?
Mice, Transgenic
1
2010
656
0.020
 Why?
Receptor, Anaphylatoxin C5a
1
2007
5
0.020
 Why?
Receptors, Chemokine
1
2007
13
0.020
 Why?
Complement Activation
1
2007
43
0.020
 Why?
Cattle
1
2007
224
0.020
 Why?
Actins
1
2007
132
0.020
 Why?
Hematopoietic Stem Cells
1
2007
215
0.020
 Why?
Fibroblasts
1
2007
386
0.020
 Why?
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (179) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department